Researchers performed a molecular analysis of neuroendocrine neoplasm (NEN) patient-derived tumor organoids (PDTOs) and their parental neoplasms.
Alnylam versus BridgeBio: The ATTR-CM debate
I coined the term “Typo-gate” to describe the misguided dustup Alnylam Pharmaceuticals executives instigated last Friday when they asserted cardiologist Sarah Cuddy made mistakes during